On December 15, the 2023 Talent Management and HR Digital Intelligence Annual Forum and Venus Awards Ceremony concluded successfully in Beijing.

Based on the three dimensions of cutting-edge concepts, innovative practices and practical results of the Venus Award "IPR" selection model, Amoul® won the China Human Resources Venus Award - "2023 Talent Management Benchmark Enterprise Award".

The China Human Resources Venus Award is hosted by the Digital HR Association (DHR Association). The review committee consists of the Department of Psychology of Beijing Normal University, representatives of world-renowned management consulting companies, and experts from industry associations. It is committed to selecting companies with outstanding practices and innovative applications, so that everyone can Excellent practices are seen and shared.

Talent is the key factor in scientific and technological innovation. As a national-level high-tech medical device enterprise with a focus on global critical and critical care fields, Amoul® has a registered capital of over RMB 100 million and strong economic strength. For a long time, it has always regarded talents and scientific research and innovation technology as the driving force for enterprise development, provided a complete scientific research and development environment and financial support, and continued to focus on the development of young talents.

Cultivate high-level talents and promote the integration of industry, academia and research. In recent years, the total funding for Amoul® scientific research projects has exceeded hundreds of millions of yuan. At the same time, it has established a postdoctoral innovation practice base, focused on the introduction of young talents, and created a group of professional R&D teams.

Relying on its own strong scientific research platform, it provides workers with abundant scientific research resources and broad development space, attracting many high-level talents to "nest" one after another.

Strengthen the training and development of innovative talents. Over the years, Amoul® has actively participated in major scientific and technological projects at the national, provincial and municipal levels, focusing on scientific research cooperation for the coordinated development of "industry, academia, research and medicine", comprehensively deploying cutting-edge technologies for critical and critical medical devices, and is committed to building a leading domestic company. The medical device scientific research platform further enhances talent transformation with strong scientific research and innovation capabilities and continues to expand brand influence.